Actionable biomarker co-expression in advanced ovarian cancer: folate receptor alpha expression and related markers.
Biomarker co-expression in advanced ovarian cancer demonstrates substantial heterogeneity, with patterns that may inform future biomarker-guided treatment combinations and sequencing strategies and support further investigation of folate receptor-α as a potentially graded rather than strictly binary biomarker.